The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

Huons N develops postbiotics for fat reduction after YT1 success

Nov 7, 2026 04:05 (2d ago)

Verifying

Huons N is developing postbiotics targeting fat reduction after commercializing its YT1 menopausal-health ingredient.
Probiotic sales reached 653.8 billion Korean won in 2025, up 2.2% year over year.
Menolacto surpassed 200 billion Korean won in cumulative sales in December last year.